|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
|
US4510245A
(en)
|
1982-11-18 |
1985-04-09 |
Chiron Corporation |
Adenovirus promoter system
|
|
GB8308235D0
(en)
|
1983-03-25 |
1983-05-05 |
Celltech Ltd |
Polypeptides
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US4968615A
(en)
|
1985-12-18 |
1990-11-06 |
Ciba-Geigy Corporation |
Deoxyribonucleic acid segment from a virus
|
|
US4925648A
(en)
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
|
GB8905592D0
(en)
|
1989-03-10 |
1989-04-19 |
Gkn Technology Ltd |
Automatic length adjuster
|
|
ES2096590T3
(es)
|
1989-06-29 |
1997-03-16 |
Medarex Inc |
Reactivos biespecificos para la terapia del sida.
|
|
US5270163A
(en)
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
|
AU667460B2
(en)
|
1990-10-05 |
1996-03-28 |
Medarex, Inc. |
Targeted immunostimulation with bispecific reagents
|
|
EP0557300B1
(en)
|
1990-10-29 |
1997-11-19 |
Chiron Corporation |
Bispecific antibodies, method of production, and uses thereof
|
|
IE921342A1
(en)
|
1991-04-26 |
1992-11-04 |
Surface Active Ltd |
Novel antibodies, and methods for their use
|
|
EP1306095A3
(en)
|
1992-03-05 |
2003-06-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
AU725609C
(en)
|
1995-08-18 |
2002-01-03 |
Morphosys Ag |
Protein/(poly)peptide libraries
|
|
AU2002365195A1
(en)
|
2001-07-12 |
2003-07-30 |
Incyte Genomics, Inc. |
Intracellular signaling molecules
|
|
SG114505A1
(en)
|
2001-10-17 |
2005-09-28 |
First Cube Pte Ltd |
System and method for facilitating delivery and return service
|
|
AU2002363960B2
(en)
|
2001-12-06 |
2008-07-10 |
Merck Sharp & Dohme Corp. |
Mitotic kinesin inhibitors
|
|
EP1620092A4
(en)
|
2003-05-07 |
2008-04-16 |
Cytokinetics Inc |
COMPOUNDS, COMPOSITIONS AND METHODS
|
|
US7498298B2
(en)
|
2003-11-06 |
2009-03-03 |
Seattle Genetics, Inc. |
Monomethylvaline compounds capable of conjugation to ligands
|
|
US7939539B2
(en)
|
2003-11-25 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Quinazolinone compounds as anticancer agents
|
|
DE10355904A1
(de)
*
|
2003-11-29 |
2005-06-30 |
Merck Patent Gmbh |
Feste Formen von anti-EGFR-Antikörpern
|
|
US7662581B1
(en)
|
2003-12-18 |
2010-02-16 |
Novartis Vaccines And Diagnostics, Inc. |
Eg5 co-crystals
|
|
KR101170925B1
(ko)
|
2004-06-18 |
2012-08-07 |
노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 |
암 치료용 키네신 방추 단백질 (ｋｓｐ) 억제제로서의ｎ-(1-(1-벤질-4-페닐-1ｈ-이미다졸-2-일)-2,2-디메틸프로필)벤자미드 유도체 및 관련 화합물
|
|
US7449486B2
(en)
|
2004-10-19 |
2008-11-11 |
Array Biopharma Inc. |
Mitotic kinesin inhibitors and methods of use thereof
|
|
US20100093767A1
(en)
|
2004-12-03 |
2010-04-15 |
Takeda San Diego, Inc. |
Mitotic Kinase Inhibitors
|
|
TW200800951A
(en)
|
2005-08-09 |
2008-01-01 |
Novartis Ag |
Substituted imidazole compounds as KSP inhibitors
|
|
DOP2006000277A
(es)
|
2005-12-12 |
2007-08-31 |
Bayer Pharmaceuticals Corp |
Anticuerpos anti mn y métodos para su utilización
|
|
AU2008205169B2
(en)
|
2007-01-05 |
2012-02-02 |
Novartis Ag |
Imidazole derivatives as kinesin spindle protein inhibitors (Eg-5)
|
|
CN111909273B
(zh)
*
|
2007-08-29 |
2024-03-26 |
塞诺菲-安万特股份有限公司 |
人源化的抗-cxcr5抗体、其衍生物及它们的应用
|
|
WO2012171020A1
(en)
|
2011-06-10 |
2012-12-13 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
EP2968591A1
(en)
|
2013-03-15 |
2016-01-20 |
Novartis AG |
Cell proliferation inhibitors and conjugates thereof
|
|
JP6522585B2
(ja)
*
|
2013-05-02 |
2019-05-29 |
アレス トレーディング ソシエテ アノニム |
Ｃｘｃｒ５に対するモノクローナル抗体
|
|
PL3086814T3
(pl)
|
2013-12-23 |
2020-12-28 |
Bayer Pharma Aktiengesellschaft |
Koniugaty środka wiążącego (ADC) z inhibitorami KSP
|
|
CN107635586B
(zh)
|
2014-12-15 |
2021-09-24 |
拜耳医药股份有限公司 |
Ksp抑制剂与无糖基化抗-tweakr抗体的抗体-药物缀合物(adc)
|
|
RU2751512C2
(ru)
*
|
2015-06-22 |
2021-07-14 |
Байер Фарма Акциенгезельшафт |
Конъюгаты антитела и лекарственного средства (adc) и конъюгаты антитела и пролекарства (apdc), содержащие ферментативно расщепляемые группы
|
|
AU2017236431A1
(en)
*
|
2016-03-24 |
2018-09-27 |
Bayer Pharma Aktiengesellschaft |
Prodrugs of cytotoxic active agents having enzymatically cleavable groups
|
|
JP7066714B2
(ja)
*
|
2016-12-21 |
2022-05-13 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
酵素的に切断可能な基を有する抗体薬物コンジュゲート（ａｄｃ）
|